ArticleFrontiers in nephrology2026

Efficacy and safety of finerenone in chronic kidney disease stages 3-4 in diabetic and non-diabetic patients with an eGFR 20-60 mL/min: a prospective cohort study.

Hayder Aledan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.